<DOC>
	<DOCNO>NCT00323076</DOCNO>
	<brief_summary>Positron Emission Tomography ( PET ) Nuclear Medicine procedure use positron emit radiolabeled tracer molecule visualize biological activity . The presence hypoxia ( low oxygen ) associate poor prognosis variety tumour type treatment strategy target hypoxic cell develop . The PET tracer [ 18 ] F-FAZA identify hypoxic area , change uptake treatment may predict tumour response .</brief_summary>
	<brief_title>Imaging Study Patients With Cancer Head &amp; Neck , Lung , Renal Cell , Brain , Lymphoma Neuroendocrine Tumours</brief_title>
	<detailed_description>The propose clinical trial Phase I/II imaging , open label , single site study . In Phase I , one 18F-FAZA PET scan conduct patient know squamous cell carcinoma Head &amp; Neck , SCLC , NSCLC , lymphoma , GGM , neuroendocrine tumours renal cell carcinoma . In Phase II , three 18F-FAZA PET scan do patient tumours follow : one pre-treatment , one mid course one post-treatment .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Male female great equal 16 year age . If female childbearing potential outside window 10 day since first day last menstrual period , negative pregnancy test require . Patients know primary suspect metastatic squamous cell carcinoma head neck , nonsmall cell small cell carcinoma lung , lymphoma , GBM ( great equal 3 glioma ) , neuroendocrine tumour , renal cell carcinoma least one lesion &gt; 1 cm diameter .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>